Literature DB >> 29949213

The therapeutic potential of kratom.

Oliver Grundmann1, Paula N Brown2, Jack Henningfield3,4, Marc Swogger5, Zach Walsh6.   

Abstract

Entities:  

Keywords:  Dietary supplement; kratom; mitragyna speciosa; mitragynine; opioids; regulation

Mesh：

Substances：

Year:  2018        PMID： 29949213     DOI： 10.1111/add.14371

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  5 in total

1.  Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.

Authors:  Rhiannon Bath; Tanner Bucholz; Amy F Buros; Darshan Singh; Kirsten E Smith; Charles A Veltri; Oliver Grundmann
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

2.  G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.

Authors:  Anna M Gutridge; Meridith T Robins; Robert J Cassell; Rajendra Uprety; Kendall L Mores; Mee Jung Ko; Gavril W Pasternak; Susruta Majumdar; Richard M van Rijn
Journal:  Br J Pharmacol       Date:  2020-01-24       Impact factor: 8.739

3.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16

Review 4.  Understanding Kratom Use: A Guide for Healthcare Providers.

Authors:  Marc T Swogger; Kirsten E Smith; Albert Garcia-Romeu; Oliver Grundmann; Charles A Veltri; Jack E Henningfield; Lorna Y Busch
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

Review 5.  Kratom Abuse Potential 2021: An Updated Eight Factor Analysis.

Authors:  Jack E Henningfield; Daniel W Wang; Marilyn A Huestis
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.